Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis-Reference-Cited by-同舟云学术

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis

Published:2020-09-07 Issue:1 Volume:15 Page:116-120
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:Clin. Respir. J.

Author:

Millar Beverley Cherie¹²³^ORCID,McCaughan John⁴,Rendall Jacqueline C.⁵,Moore John E.¹²³^ORCID

Affiliation:

1. Department of Bacteriology Northern Ireland Public Health Laboratory Belfast City Hospital Belfast UK

2. School of Medicine Dentistry and Biomedical Science The Wellcome‐Wolfson Institute for Experimental Medicine Queen's University Belfast UK

3. School of Biomedical Sciences Ulster University Coleraine UK

4. Department of Medical Microbiology The Royal Group of Hospitals Belfast UK

5. Northern Ireland Regional Adult Cystic Fibrosis Centre Level 8 Belfast City Hospital Belfast UK

Publisher

Wiley

Subject

Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/crj.13262

Reference11 articles.

1. Clinical implications ofPseudomonas aeruginosalocation in the lungs of patients with cystic fibrosis

2. Increasing burden of antimicrobial resistance in Pseudomonas aeruginosa from adult patients with cystic fibrosis (CF) in Northern Ireland: Then and now;Gramegna A;Ulster Med J,2018

3. Antibiotic resistance evolution ofPseudomonas aeruginosain cystic fibrosis patients (2010-2013)

4. Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro susceptibility to delafloxacin of Pseudomonas aeruginosa with resistance to other quinolones (ciprofloxacin and levofloxacin);Clinical Microbiology and Infection;2023-12

2. Updated Review on Clinically-Relevant Properties of Delafloxacin;Antibiotics;2023-07-28

3. Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant Pseudomonas aeruginosa in an In Vitro Cystic Fibrosis Sputum Model;Antibiotics;2023-06-20

4. Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT);Revista Española de Quimioterapia;2023-04-05

5. A review on biofilms and the currently available antibiofilm approaches: Matrix-destabilizing hydrolases and anti-bacterial peptides as promising candidates for the food industries;International Journal of Biological Macromolecules;2022-10